TABLE 2

Male Health Guidelines (86107)

Specialty Organizations
Bright FuturesOther AAPUSPSTFAMA GAPSCDCCRACSADA
Adolescent well visit
 Preventative care visits (frequency)YearlyYearlyYearly
 Strengths-based approachesXX
 ConfidentialityXXX
Chronic illness/cardiovascular
 BPXXXaX
 BMIXXXbXX
 Diabetes screeningXX
 (fasting glucose, HbA1c, frequency)
 Lipid screening (frequency)XXXcXXXd
 Tobacco useXXX
 Substance use and mental health
 Depression screeningXXX
 Alcohol and other substance useXXX
Violence and injury
 Screening and counseling on violenceXXeX
 Seat belt and drinking while driving counselingXXeX
Sexual health
Chlamydia trachomatisXXbXe,gXXg,h
 GonorrheaXXbfXh
Trichomonas vaginalisfXXh
 HIVXXXfXXh
 SyphilisXfXXh
 Testicular self-examinationiXcXci
 Testicular cancer screeningiXcXcX
  • AMA, American Medical Association; BF, Bright Futures; USPSTF, US Preventive Services Task Force; CR, Cochrane Reviews; ACS, American Cancer Society; ADA, American Diabetes Association; X, recommendations available.

  • a Recommendations only for adults 18 yr and older.

  • b Recommendation to measure BMI, but no recommendation for interval for screening.

  • c Recommendation against routine screening owing to lack of evidence-based benefit in children.

  • d Recommendations specifically for children/adolescents with diabetes mellitus.

  • e Insufficient evidence or benefits of screening are unknown.

  • f Recommendations for behavioral counseling to prevent STIs.

  • g No recommendation to perform routine screening for C. trachomatis in sexually active young men owing to lack of evidence of efficacy and cost-effectiveness. However, screening of sexually active young men should be considered in clinical settings associated with high prevalence of C. trachomatis.

  • h Specific recommendations for MSM.

  • i Refers to other agencies guidelines: CDC and/or USPTF.